
Journal of Medicinal Chemistry p. 1086 - 1094 (1991)
Update date:2022-07-31
Topics:
Showell, Graham A.
Gibbons, Tracey L.
Kneen, Clare O.
MacLeod, Angus M.
Merchant, Kevin
et al.
Recent studies have described novel azabicycle-based muscarinic agonists which readily penetrate into the central nervous system and are capable of displaying high efficacy at cortical sites.The current paper describes the synthesis and biochemical assesment of semirigid muscarinic ligands which were used to map the requirements of the cortical muscarinic receptor and to study the degree of conformational flexibility required to cause receptor activation.Analogues 6 and 9 provide high-efficacy muscarinic agonist at cortical sites; however, C-alkylation on the tetrahydropyridine ring resulted in more rigid analogues and showed lower predicted efficacy.Molecular mechanics calculations indicated a preference for the E rotameric form.This conformation was also observed in the X-ray crystal structure of ethenyloxadiazole 12.The new compounds were tested in biochemical assay designed to measure receptor affinity and to predict cortical efficacy.
View MoreContact:+86-535-8888888
Address:No.161 Haishi Rd.
Contact:86-27-84888681
Address:Wuhan economic & technology development zone
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Anhui Gusheng Import&Export CO.,LTD
Contact:86-551-63662296
Address:Jinzhai Road NO.162 ,hefei, china
Contact:+8618766299236
Address:ROOM808, BUILDING2,NO.230 SHEN ZHEN ROAD, LAOSHAN DISTRICT
Doi:10.1021/ja00967a011
(1966)Doi:10.1016/S0040-4020(01)01061-4
(2001)Doi:10.1021/ja01196a036
(1947)Doi:10.1021/ja01600a036
(1956)Doi:10.1021/ol502515b
(2014)Doi:10.1021/jm00092a020
(1992)